GeoVax vaccine targetting virus in two places shows promise; virus may become resistant to antibody… Reuters Mar 14, 2022 GeoVax's GEO-CM04S1 induces immune responses that target the spike protein on the surface of the virus. However, it also targets…
Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused Reuters Mar 3, 2022 Inovio has paused enrollment in the trial to prepare for this potential change, and said interim efficacy data from the trial will…
India’s first homegrown mRNA COVID-19 vaccine currently under final clinical trial stages:… Press Trust of India Feb 11, 2022 The vaccine is being developed by Pune-based Gennova Biopharmaceuticals, informed Dr VK Paul, Member (health), NITI Aayog
DCGI gives nod to phase-I clinical trial of COVID-19 vaccine by Reliance Life Sciences Press Trust of India Sep 6, 2021 The trials will be conducted at eight sites in Maharashtra